Have your own idea? Try our Stock Screener
Over the last 7 days, the Healthtech industry has risen 4.7%, driven by gains from Pro Medicus of 4.8%. Meanwhile, 4DMedical actually underperformed within the industry, shrinking 6.3% in the last week. In the last 12 months, the industry was up 122%. Earnings are forecast to grow by 21% annually.
Has the Australian Healthtech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 21 Nov 2024 | AU$23.6b | AU$582.1m | -AU$62,909,723.04 | 201.8x | -375.6x | 40.6x |
Sat, 19 Oct 2024 | AU$21.4b | AU$579.7m | -AU$62,390,384.47 | 243.4x | -343.7x | 37x |
Mon, 16 Sep 2024 | AU$18.8b | AU$581.4m | -AU$62,713,913.86 | 211.6x | -299.6x | 32.3x |
Wed, 14 Aug 2024 | AU$15.1b | AU$535.2m | -AU$82,406,429.22 | 110.2x | -183.4x | 28.2x |
Fri, 12 Jul 2024 | AU$15.4b | AU$531.9m | -AU$81,301,672.69 | 112.7x | -189.8x | 29x |
Sun, 09 Jun 2024 | AU$14.6b | AU$535.0m | -AU$82,259,894.92 | 106x | -177.1x | 27.2x |
Tue, 07 May 2024 | AU$13.3b | AU$567.5m | -AU$89,821,665.86 | 98.2x | -148.5x | 23.5x |
Thu, 04 Apr 2024 | AU$12.3b | AU$571.2m | -AU$103,037,081.64 | 89.4x | -119.8x | 21.6x |
Sat, 02 Mar 2024 | AU$12.5b | AU$576.7m | -AU$98,504,115.56 | 90.3x | -127x | 21.7x |
Mon, 29 Jan 2024 | AU$12.2b | AU$529.9m | -AU$141,017,502.00 | 105.5x | -86.6x | 23.1x |
Wed, 27 Dec 2023 | AU$11.8b | AU$525.6m | -AU$138,905,120.00 | 105.2x | -84.6x | 22.4x |
Fri, 24 Nov 2023 | AU$10.9b | AU$528.2m | -AU$106,927,317.00 | 100.4x | -101.7x | 20.6x |
Sun, 22 Oct 2023 | AU$9.7b | AU$528.7m | -AU$107,906,889.00 | 88.6x | -90.1x | 18.4x |
Tue, 19 Sep 2023 | AU$9.1b | AU$528.2m | -AU$112,948,489.00 | 85.5x | -80.2x | 17.1x |
Thu, 17 Aug 2023 | AU$9.1b | AU$522.9m | -AU$144,904,305.00 | 84.6x | -62.6x | 17.4x |
Sat, 15 Jul 2023 | AU$8.6b | AU$498.3m | -AU$152,950,742.00 | 95x | -56.4x | 17.3x |
Mon, 12 Jun 2023 | AU$8.3b | AU$497.3m | -AU$151,340,682.00 | 93.3x | -54.5x | 16.6x |
Wed, 10 May 2023 | AU$7.9b | AU$493.7m | -AU$145,626,921.00 | 89.1x | -54.4x | 16.1x |
Fri, 07 Apr 2023 | AU$8.1b | AU$494.4m | -AU$145,556,806.00 | 90x | -55.8x | 16.4x |
Sun, 05 Mar 2023 | AU$7.8b | AU$488.2m | -AU$137,672,812.00 | 87.6x | -56.4x | 15.9x |
Tue, 31 Jan 2023 | AU$8.6b | AU$438.9m | -AU$154,734,130.00 | 92.8x | -55.4x | 19.5x |
Thu, 29 Dec 2022 | AU$7.2b | AU$443.3m | -AU$155,467,806.00 | 79x | -46.3x | 16.3x |
Sat, 26 Nov 2022 | AU$7.8b | AU$443.3m | -AU$155,388,122.00 | 84.6x | -50.1x | 17.6x |
Mon, 24 Oct 2022 | AU$7.0b | AU$442.5m | -AU$156,796,521.00 | 74.6x | -44.7x | 15.8x |
Wed, 21 Sep 2022 | AU$7.3b | AU$435.7m | -AU$155,165,022.00 | 76.7x | -47x | 16.7x |
Fri, 19 Aug 2022 | AU$7.3b | AU$387.8m | -AU$130,671,315.00 | 84.9x | -56.1x | 18.9x |
Sun, 17 Jul 2022 | AU$6.2b | AU$386.5m | -AU$130,590,335.00 | 71.9x | -47.2x | 15.9x |
Tue, 14 Jun 2022 | AU$5.8b | AU$384.4m | -AU$131,184,081.00 | 67.1x | -44x | 15x |
Thu, 12 May 2022 | AU$6.1b | AU$383.3m | -AU$132,421,654.00 | 68.9x | -46.2x | 16x |
Sat, 09 Apr 2022 | AU$7.0b | AU$378.2m | -AU$133,773,368.00 | 80.9x | -52.5x | 18.6x |
Mon, 07 Mar 2022 | AU$6.7b | AU$376.3m | -AU$129,426,994.00 | 76.1x | -52x | 17.9x |
Wed, 02 Feb 2022 | AU$7.2b | AU$302.0m | -AU$137,930,733.00 | 100x | -52.1x | 23.8x |
Fri, 31 Dec 2021 | AU$9.2b | AU$299.8m | -AU$137,158,863.00 | 135.3x | -67.1x | 30.7x |
Sun, 28 Nov 2021 | AU$9.0b | AU$301.4m | -AU$137,736,828.00 | 128.7x | -65.6x | 30x |
-65.6x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | 1.47% | |
Healthcare | -2.04% | |
Healthtech | 4.68% | |
Healthtech | 4.68% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
PME Pro Medicus | AU$214.62 | 4.8% +AU$1.0b | 142.3% | PE270.9x | |
ALC Alcidion Group | AU$0.066 | 15.8% +AU$12.1m | -4.3% | PS2.4x | |
CGS Cogstate | AU$0.99 | 4.2% +AU$6.8m | -35.5% | PE20.4x | |
SHG Singular Health Group | AU$0.12 | 36.9% +AU$6.4m | 202.6% | PS25.5x | |
MDR MedAdvisor | AU$0.30 | 3.4% +AU$5.5m | 53.8% | PE208.8x |